115 search results for: pediatric
Donald Leung, MD, PhD
Chair of Pediatric Allergy-Immunology at the National Jewish Health, Professor of Pediatrics at the University of Colorado Denver School of Medicine, US
Salvatore Oliva, MD, PhD
Professor of Medicine | Associate Professor of Pediatrics in the Maternal and Child Health Department | Sapienza University of Rome; Consultant Pediatric Gastroenterologist | Umberto I University Hospital, Rome, Italy
Jonathan Spergel, MD, PhD
Professor of Pediatrics | Perelman School of Medicine, University of Pennsylvania; Chief of Allergy Section and Director of the Center for Pediatric Eosinophilic Disorders | Children’s Hospital of Philadelphia, Pennsylvania, United States
Carolina Gutiérrez Junquera, MD, PhD
Carolina Gutiérrez Junquera, MD, PhD, is an associate professor of Pediatrics at the Universidad Autónoma of Madrid, Spain, and a consultant pediatric gastroenterologist at University Hospital Puerta de Hierro Majadahonda in Madrid.
Alexandra Papadopoulou, MD
Chief of the Division of Pediatric Gastroenterology and Hepatology of the First Department of Pediatrics | National and Kapodistrian University of Athens; Head of the Gastroenterology Department | Children’s Hospital Agia Sofia, Athens, Greece
ADVENT at WCPD 2025
The ADVENT symposium at the 15th World Congress of Pediatric Dermatology (WCPD) will focus on discussions around disease modification in atopic dermatitis (AD) in three main topic areas: restoring the skin barrier, reducing non-atopic comorbidities, and stopping the atopic march in pediatric patients with AD aged 6 months to 11 years.
The Benefits of Early Intervention in Reducing the Burden of Disease in Children With Atopic Dermatitis
This page presents educational material, infographics, and video highlights from our recent ADVENT symposia, including the 2025 World Congress of Pediatric Dermatology (WCPD) in Buenos Aires, Argentina, exploring the pathophysiology of type 2 inflammation and atopic dermatitis, the burden of disease leading to cumulative life course impairment (CLCI), and the risk of the atopic march in pediatric patients with atopic dermatitis.
Emerging Data on Advanced Systemic Treatments for Children With AD
This video from the May 2024 ADVENT symposium at ESPD’s Annual Meeting in Košice, Slovakia features Dr. Eulàlia Baselga reviewing the systemic treatment landscape for children under 12 years of age with AD in the EU. Dr. Baselga also discusses the latest clinical data on the use of baricitinib in pediatric patients aged 2 to 17 years, and both clinical and real-world data on the efficacy and safety of dupilumab in pediatric patients with AD aged as young as 6 months.
The Benefits of Early Intervention in AD: More Than Skin Deep
Many AD treatment goals focus on clinical manifestations, so that if a patient is free of lesions, their disease is considered well controlled. However, the inflammatory process underlying AD reaches far beyond the skin, affecting patients in unique ways at different stages of their lives. Education on the importance of treating AD beyond the skin and altering the treatment approach to fit the individual patient will help improve clinical management and reduce long-term patient burden.
Jerry Ellen Schonfeld, CPNP
Certified Pediatric Nurse Practitioner
Eckard Hamelmann, MD, PhD
Professor of Pediatrics | Evangelic Hospital, Bielefeld, Germany
Marlies de Graaf, MD, PhD
Pediatric Dermatologist, University Medical Center of Utrecht, The Netherlands
